Industry Research Reports
Home > Reports > Service & Software > Global Clinical Reference Laboratory Molecular Diagnostic Services Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
Global Clinical Reference Laboratory Molecular Diagnostic Services Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
Industry: Service & Software
Published Date: 2025-04-13
Pages: 103 Pages
Report ld: 4707105
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Clinical Reference Laboratory Molecular Diagnostic Services Market Size(US$)
CAGR 2025-2031
5.8%
Market Size,2031
USD 9,639
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 6,876 million
Market Forecast in 2031(Value)
US$ 9,639 million
CAGR
5.8%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Clinical Reference Laboratory Molecular Diagnostic Services market size was US$ 6500 million in 2024 and is forecast to a readjusted size of US$ 9639 million by 2031 with a CAGR of 5.8% during the forecast period 2025-2031.
Clinical reference laboratory molecular diagnostic services refer to the analysis of biological samples (such as blood, tissue, etc.) of patients through molecular biology techniques (such as PCR, gene sequencing, etc.) to detect genetic material (DNA, RNA) changes related to diseases, thereby providing scientific basis for disease diagnosis, treatment, and prognosis. Its application areas include disease diagnosis, drug development, personalized medicine, forensic identification, etc.
In recent years, the market size of clinical reference laboratory molecular diagnostic services has been continuously growing. The main driving factors include the application of new technologies such as high-throughput sequencing and digital PCR, the gradual popularization of personalized medicine, the increasing demand for diagnostic testing services, and policy support from governments around the world. In the global market, international giants such as Quest Diagnostics, Eurofins Scientific, and Genomic Health. In the Chinese market, local enterprises such as BGI Genomics and Daan Genomics have gradually enhanced their competitiveness through technological innovation and market expansion. In the future, the development trend of the market lies in intelligence and automation, multi omics integration, remote healthcare, and home testing. Specifically, the laboratory will introduce more automated equipment and artificial intelligence technology to improve detection efficiency and accuracy, while combining genomic, proteomic, and metabolomic data to provide a more comprehensive disease diagnosis plan. With the popularization of technology, molecular diagnostic services will be extended to households and communities to meet the needs of more scenarios.
The global Clinical Reference Laboratory Molecular Diagnostic Services market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2020-2031.
MARKET SEGMENTATION
By Company
- Quest Diagnostics
- Eurofins Scientific
- Mayo Clinic Laboratories
- Genomic Health
- Clinical Reference Laboratory
- Molecular Pathology Laboratory Network
- Opko Health
- NantHealth
- ARUP Laboratories
- Viant Medical
- Sonic Healthcare
- Fulgent Genetics
- Laboratory Corporation of America Holdings
- BGI Genomics
- Daan Gene
- Guangdong Hybribio Biotech
- Jiangsu Bioperfectus Technologies
- Maccura Biotechnology
- Guangzhou Wondfo Biotech
- GoBroad Healthcare
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Nucleic Acid Amplification Testing
- Nucleic Acid Hybridization Testing
- Gene Sequencing
- Gene Chip Technology
- Others
Segment by Application
- Disease Diagnosis
- Drug Development
- Personalized Healthcare
- Medicolegal Expertise
- Others
CHAPTER OUTLINE
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Clinical Reference Laboratory Molecular Diagnostic Services market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Nucleic Acid Hybridization Testing in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Drug Development in India).
Chapter 6: Regional revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Clinical Reference Laboratory Molecular Diagnostic Services value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Report Overview
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031
1.2.2 Nucleic Acid Amplification Testing
1.2.3 Nucleic Acid Hybridization Testing
1.2.4 Gene Sequencing
1.2.5 Gene Chip Technology
1.2.6 Others
1.3 Market by Application
1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031
1.3.2 Disease Diagnosis
1.3.3 Drug Development
1.3.4 Personalized Healthcare
1.3.5 Medicolegal Expertise
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Clinical Reference Laboratory Molecular Diagnostic Services Market Perspective (2020-2031)
2.2 Global Market Size by Region: 2020 VS 2024 VS 2031
2.3 Global Clinical Reference Laboratory Molecular Diagnostic Services Revenue Market Share by Region (2020-2025)
2.4 Global Clinical Reference Laboratory Molecular Diagnostic Services Revenue Forecast by Region (2026-2031)
2.5 Major Region and Emerging Market Analysis
2.5.1 North America Clinical Reference Laboratory Molecular Diagnostic Services Market Size and Prospective (2020-2031)
2.5.2 Europe Clinical Reference Laboratory Molecular Diagnostic Services Market Size and Prospective (2020-2031)
2.5.3 Asia-Pacific Clinical Reference Laboratory Molecular Diagnostic Services Market Size and Prospective (2020-2031)
2.5.4 Latin America Clinical Reference Laboratory Molecular Diagnostic Services Market Size and Prospective (2020-2031)
2.5.5 Middle East & Africa Clinical Reference Laboratory Molecular Diagnostic Services Market Size and Prospective (2020-2031)
3 Breakdown Data by Type
3.1 Global Clinical Reference Laboratory Molecular Diagnostic Services Historic Market Size by Type (2020-2025)
3.2 Global Clinical Reference Laboratory Molecular Diagnostic Services Forecasted Market Size by Type (2026-2031)
3.3 Different Types Clinical Reference Laboratory Molecular Diagnostic Services Representative Players
4 Breakdown Data by Application
4.1 Global Clinical Reference Laboratory Molecular Diagnostic Services Historic Market Size by Application (2020-2025)
4.2 Global Clinical Reference Laboratory Molecular Diagnostic Services Forecasted Market Size by Application (2026-2031)
4.3 New Sources of Growth in Clinical Reference Laboratory Molecular Diagnostic Services Application
5 Competition Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Clinical Reference Laboratory Molecular Diagnostic Services Players by Revenue (2020-2025)
5.1.2 Global Clinical Reference Laboratory Molecular Diagnostic Services Revenue Market Share by Players (2020-2025)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Clinical Reference Laboratory Molecular Diagnostic Services Revenue
5.4 Global Clinical Reference Laboratory Molecular Diagnostic Services Market Concentration Analysis
5.4.1 Global Clinical Reference Laboratory Molecular Diagnostic Services Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Clinical Reference Laboratory Molecular Diagnostic Services Revenue in 2024
5.5 Global Key Players of Clinical Reference Laboratory Molecular Diagnostic Services Head office and Area Served
5.6 Global Key Players of Clinical Reference Laboratory Molecular Diagnostic Services, Product and Application
5.7 Global Key Players of Clinical Reference Laboratory Molecular Diagnostic Services, Date of Enter into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments and Downstream
6.1.1 North America Clinical Reference Laboratory Molecular Diagnostic Services Revenue by Company (2020-2025)
6.1.2 North America Market Size by Type
6.1.2.1 North America Clinical Reference Laboratory Molecular Diagnostic Services Market Size by Type (2020-2025)
6.1.2.2 North America Clinical Reference Laboratory Molecular Diagnostic Services Market Share by Type (2020-2025)
6.1.3 North America Market Size by Application
6.1.3.1 North America Clinical Reference Laboratory Molecular Diagnostic Services Market Size by Application (2020-2025)
6.1.3.2 North America Clinical Reference Laboratory Molecular Diagnostic Services Market Share by Application (2020-2025)
6.1.4 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments and Downstream
6.2.1 Europe Clinical Reference Laboratory Molecular Diagnostic Services Revenue by Company (2020-2025)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe Clinical Reference Laboratory Molecular Diagnostic Services Market Size by Type (2020-2025)
6.2.2.2 Europe Clinical Reference Laboratory Molecular Diagnostic Services Market Share by Type (2020-2025)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe Clinical Reference Laboratory Molecular Diagnostic Services Market Size by Application (2020-2025)
6.2.3.2 Europe Clinical Reference Laboratory Molecular Diagnostic Services Market Share by Application (2020-2025)
6.2.4 Europe Market Trend and Opportunities
6.3 Asia-Pacific Market: Players, Segments and Downstream
6.3.1 Asia-Pacific Clinical Reference Laboratory Molecular Diagnostic Services Revenue by Company (2020-2025)
6.3.2 Asia-Pacific Market Size by Type
6.3.2.1 Asia-Pacific Clinical Reference Laboratory Molecular Diagnostic Services Market Size by Type (2020-2025)
6.3.2.2 Asia-Pacific Clinical Reference Laboratory Molecular Diagnostic Services Market Share by Type (2020-2025)
6.3.3 Asia-Pacific Market Size by Application
6.3.3.1 Asia-Pacific Clinical Reference Laboratory Molecular Diagnostic Services Market Size by Application (2020-2025)
6.3.3.2 Asia-Pacific Clinical Reference Laboratory Molecular Diagnostic Services Market Share by Application (2020-2025)
6.3.4 Asia-Pacific Market Trend and Opportunities
6.4 Latin America Market: Players, Segments and Downstream
6.4.1 Latin America Clinical Reference Laboratory Molecular Diagnostic Services Revenue by Company (2020-2025)
6.4.2 Latin America Market Size by Type
6.4.2.1 Latin America Clinical Reference Laboratory Molecular Diagnostic Services Market Size by Type (2020-2025)
6.4.2.2 Latin America Clinical Reference Laboratory Molecular Diagnostic Services Market Share by Type (2020-2025)
6.4.3 Latin America Market Size by Application
6.4.3.1 Latin America Clinical Reference Laboratory Molecular Diagnostic Services Market Size by Application (2020-2025)
6.4.3.2 Latin America Clinical Reference Laboratory Molecular Diagnostic Services Market Share by Application (2020-2025)
6.4.4 Latin America Market Trend and Opportunities
6.5 Middle East & Africa Market: Players, Segments and Downstream
6.5.1 Middle East & Africa Clinical Reference Laboratory Molecular Diagnostic Services Revenue by Company (2020-2025)
6.5.2 Middle East & Africa Market Size by Type
6.5.2.1 Middle East & Africa Clinical Reference Laboratory Molecular Diagnostic Services Market Size by Type (2020-2025)
6.5.2.2 Middle East & Africa Clinical Reference Laboratory Molecular Diagnostic Services Market Share by Type (2020-2025)
6.5.3 Middle East & Africa Market Size by Application
6.5.3.1 Middle East & Africa Clinical Reference Laboratory Molecular Diagnostic Services Market Size by Application (2020-2025)
6.5.3.2 Middle East & Africa Clinical Reference Laboratory Molecular Diagnostic Services Market Share by Application (2020-2025)
6.5.4 Middle East & Africa Market Trend and Opportunities
7 Key Players Profiles
7.1 Quest Diagnostics
7.1.1 Quest Diagnostics Company Details
7.1.2 Quest Diagnostics Business Overview
7.1.3 Quest Diagnostics Clinical Reference Laboratory Molecular Diagnostic Services Introduction
7.1.4 Quest Diagnostics Revenue in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025)
7.1.5 Quest Diagnostics Recent Development
7.2 Eurofins Scientific
7.2.1 Eurofins Scientific Company Details
7.2.2 Eurofins Scientific Business Overview
7.2.3 Eurofins Scientific Clinical Reference Laboratory Molecular Diagnostic Services Introduction
7.2.4 Eurofins Scientific Revenue in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025)
7.2.5 Eurofins Scientific Recent Development
7.3 Mayo Clinic Laboratories
7.3.1 Mayo Clinic Laboratories Company Details
7.3.2 Mayo Clinic Laboratories Business Overview
7.3.3 Mayo Clinic Laboratories Clinical Reference Laboratory Molecular Diagnostic Services Introduction
7.3.4 Mayo Clinic Laboratories Revenue in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025)
7.3.5 Mayo Clinic Laboratories Recent Development
7.4 Genomic Health
7.4.1 Genomic Health Company Details
7.4.2 Genomic Health Business Overview
7.4.3 Genomic Health Clinical Reference Laboratory Molecular Diagnostic Services Introduction
7.4.4 Genomic Health Revenue in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025)
7.4.5 Genomic Health Recent Development
7.5 Clinical Reference Laboratory
7.5.1 Clinical Reference Laboratory Company Details
7.5.2 Clinical Reference Laboratory Business Overview
7.5.3 Clinical Reference Laboratory Clinical Reference Laboratory Molecular Diagnostic Services Introduction
7.5.4 Clinical Reference Laboratory Revenue in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025)
7.5.5 Clinical Reference Laboratory Recent Development
7.6 Molecular Pathology Laboratory Network
7.6.1 Molecular Pathology Laboratory Network Company Details
7.6.2 Molecular Pathology Laboratory Network Business Overview
7.6.3 Molecular Pathology Laboratory Network Clinical Reference Laboratory Molecular Diagnostic Services Introduction
7.6.4 Molecular Pathology Laboratory Network Revenue in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025)
7.6.5 Molecular Pathology Laboratory Network Recent Development
7.7 Opko Health
7.7.1 Opko Health Company Details
7.7.2 Opko Health Business Overview
7.7.3 Opko Health Clinical Reference Laboratory Molecular Diagnostic Services Introduction
7.7.4 Opko Health Revenue in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025)
7.7.5 Opko Health Recent Development
7.8 NantHealth
7.8.1 NantHealth Company Details
7.8.2 NantHealth Business Overview
7.8.3 NantHealth Clinical Reference Laboratory Molecular Diagnostic Services Introduction
7.8.4 NantHealth Revenue in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025)
7.8.5 NantHealth Recent Development
7.9 ARUP Laboratories
7.9.1 ARUP Laboratories Company Details
7.9.2 ARUP Laboratories Business Overview
7.9.3 ARUP Laboratories Clinical Reference Laboratory Molecular Diagnostic Services Introduction
7.9.4 ARUP Laboratories Revenue in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025)
7.9.5 ARUP Laboratories Recent Development
7.10 Viant Medical
7.10.1 Viant Medical Company Details
7.10.2 Viant Medical Business Overview
7.10.3 Viant Medical Clinical Reference Laboratory Molecular Diagnostic Services Introduction
7.10.4 Viant Medical Revenue in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025)
7.10.5 Viant Medical Recent Development
7.11 Sonic Healthcare
7.11.1 Sonic Healthcare Company Details
7.11.2 Sonic Healthcare Business Overview
7.11.3 Sonic Healthcare Clinical Reference Laboratory Molecular Diagnostic Services Introduction
7.11.4 Sonic Healthcare Revenue in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025)
7.11.5 Sonic Healthcare Recent Development
7.12 Fulgent Genetics
7.12.1 Fulgent Genetics Company Details
7.12.2 Fulgent Genetics Business Overview
7.12.3 Fulgent Genetics Clinical Reference Laboratory Molecular Diagnostic Services Introduction
7.12.4 Fulgent Genetics Revenue in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025)
7.12.5 Fulgent Genetics Recent Development
7.13 Laboratory Corporation of America Holdings
7.13.1 Laboratory Corporation of America Holdings Company Details
7.13.2 Laboratory Corporation of America Holdings Business Overview
7.13.3 Laboratory Corporation of America Holdings Clinical Reference Laboratory Molecular Diagnostic Services Introduction
7.13.4 Laboratory Corporation of America Holdings Revenue in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025)
7.13.5 Laboratory Corporation of America Holdings Recent Development
7.14 BGI Genomics
7.14.1 BGI Genomics Company Details
7.14.2 BGI Genomics Business Overview
7.14.3 BGI Genomics Clinical Reference Laboratory Molecular Diagnostic Services Introduction
7.14.4 BGI Genomics Revenue in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025)
7.14.5 BGI Genomics Recent Development
7.15 Daan Gene
7.15.1 Daan Gene Company Details
7.15.2 Daan Gene Business Overview
7.15.3 Daan Gene Clinical Reference Laboratory Molecular Diagnostic Services Introduction
7.15.4 Daan Gene Revenue in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025)
7.15.5 Daan Gene Recent Development
7.16 Guangdong Hybribio Biotech
7.16.1 Guangdong Hybribio Biotech Company Details
7.16.2 Guangdong Hybribio Biotech Business Overview
7.16.3 Guangdong Hybribio Biotech Clinical Reference Laboratory Molecular Diagnostic Services Introduction
7.16.4 Guangdong Hybribio Biotech Revenue in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025)
7.16.5 Guangdong Hybribio Biotech Recent Development
7.17 Jiangsu Bioperfectus Technologies
7.17.1 Jiangsu Bioperfectus Technologies Company Details
7.17.2 Jiangsu Bioperfectus Technologies Business Overview
7.17.3 Jiangsu Bioperfectus Technologies Clinical Reference Laboratory Molecular Diagnostic Services Introduction
7.17.4 Jiangsu Bioperfectus Technologies Revenue in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025)
7.17.5 Jiangsu Bioperfectus Technologies Recent Development
7.18 Maccura Biotechnology
7.18.1 Maccura Biotechnology Company Details
7.18.2 Maccura Biotechnology Business Overview
7.18.3 Maccura Biotechnology Clinical Reference Laboratory Molecular Diagnostic Services Introduction
7.18.4 Maccura Biotechnology Revenue in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025)
7.18.5 Maccura Biotechnology Recent Development
7.19 Guangzhou Wondfo Biotech
7.19.1 Guangzhou Wondfo Biotech Company Details
7.19.2 Guangzhou Wondfo Biotech Business Overview
7.19.3 Guangzhou Wondfo Biotech Clinical Reference Laboratory Molecular Diagnostic Services Introduction
7.19.4 Guangzhou Wondfo Biotech Revenue in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025)
7.19.5 Guangzhou Wondfo Biotech Recent Development
7.20 GoBroad Healthcare
7.20.1 GoBroad Healthcare Company Details
7.20.2 GoBroad Healthcare Business Overview
7.20.3 GoBroad Healthcare Clinical Reference Laboratory Molecular Diagnostic Services Introduction
7.20.4 GoBroad Healthcare Revenue in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025)
7.20.5 GoBroad Healthcare Recent Development
8 Clinical Reference Laboratory Molecular Diagnostic Services Market Dynamics
8.1 Clinical Reference Laboratory Molecular Diagnostic Services Industry Trends
8.2 Clinical Reference Laboratory Molecular Diagnostic Services Market Drivers
8.3 Clinical Reference Laboratory Molecular Diagnostic Services Market Challenges
8.4 Clinical Reference Laboratory Molecular Diagnostic Services Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Global Clinical Reference Laboratory Molecular Diagnostic Services Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Clinical Reference Laboratory Molecular Diagnostic Services Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Market Clinical Reference Laboratory Molecular Diagnostic Services Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Clinical Reference Laboratory Molecular Diagnostic Services Revenue (US$ Million) Market Share by Region (2020-2025)
Table 5. Global Clinical Reference Laboratory Molecular Diagnostic Services Revenue Share by Region (2020-2025)
Table 6. Global Clinical Reference Laboratory Molecular Diagnostic Services Revenue (US$ Million) Forecast by Region (2026-2031)
Table 7. Global Clinical Reference Laboratory Molecular Diagnostic Services Revenue Share Forecast by Region (2026-2031)
Table 8. Global Clinical Reference Laboratory Molecular Diagnostic Services Market Size by Type (2020-2025) & (US$ Million)
Table 9. Global Clinical Reference Laboratory Molecular Diagnostic Services Revenue Market Share by Type (2020-2025)
Table 10. Global Clinical Reference Laboratory Molecular Diagnostic Services Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 11. Global Clinical Reference Laboratory Molecular Diagnostic Services Revenue Market Share by Type (2026-2031)
Table 12. Representative Players of Each Type
Table 13. Global Clinical Reference Laboratory Molecular Diagnostic Services Market Size by Application (2020-2025) & (US$ Million)
Table 14. Global Clinical Reference Laboratory Molecular Diagnostic Services Revenue Market Share by Application (2020-2025)
Table 15. Global Clinical Reference Laboratory Molecular Diagnostic Services Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 16. Global Clinical Reference Laboratory Molecular Diagnostic Services Revenue Market Share by Application (2026-2031)
Table 17. New Sources of Growth in Clinical Reference Laboratory Molecular Diagnostic Services Application
Table 18. Global Clinical Reference Laboratory Molecular Diagnostic Services Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global Clinical Reference Laboratory Molecular Diagnostic Services Market Share by Players (2020-2025)
Table 20. Global Top Clinical Reference Laboratory Molecular Diagnostic Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Clinical Reference Laboratory Molecular Diagnostic Services as of 2024)
Table 21. Ranking of Global Top Clinical Reference Laboratory Molecular Diagnostic Services Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by Clinical Reference Laboratory Molecular Diagnostic Services Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of Clinical Reference Laboratory Molecular Diagnostic Services, Headquarters and Area Served
Table 24. Global Key Players of Clinical Reference Laboratory Molecular Diagnostic Services, Product and Application
Table 25. Global Key Players of Clinical Reference Laboratory Molecular Diagnostic Services, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America Clinical Reference Laboratory Molecular Diagnostic Services Revenue by Company (2020-2025) & (US$ Million)
Table 28. North America Clinical Reference Laboratory Molecular Diagnostic Services Revenue Market Share by Company (2020-2025)
Table 29. North America Clinical Reference Laboratory Molecular Diagnostic Services Market Size by Type (2020-2025) & (US$ Million)
Table 30. North America Clinical Reference Laboratory Molecular Diagnostic Services Market Size by Application (2020-2025) & (US$ Million)
Table 31. Europe Clinical Reference Laboratory Molecular Diagnostic Services Revenue by Company (2020-2025) & (US$ Million)
Table 32. Europe Clinical Reference Laboratory Molecular Diagnostic Services Revenue Market Share by Company (2020-2025)
Table 33. Europe Clinical Reference Laboratory Molecular Diagnostic Services Market Size by Type (2020-2025) & (US$ Million)
Table 34. Europe Clinical Reference Laboratory Molecular Diagnostic Services Market Size by Application (2020-2025) & (US$ Million)
Table 35. Asia-Pacific Clinical Reference Laboratory Molecular Diagnostic Services Revenue by Company (2020-2025) & (US$ Million)
Table 36. Asia-Pacific Clinical Reference Laboratory Molecular Diagnostic Services Revenue Market Share by Company (2020-2025)
Table 37. Asia-Pacific Clinical Reference Laboratory Molecular Diagnostic Services Market Size by Type (2020-2025) & (US$ Million)
Table 38. Asia-Pacific Clinical Reference Laboratory Molecular Diagnostic Services Market Size by Application (2020-2025) & (US$ Million)
Table 39. Latin America Clinical Reference Laboratory Molecular Diagnostic Services Revenue by Company (2020-2025) & (US$ Million)
Table 40. Latin America Clinical Reference Laboratory Molecular Diagnostic Services Revenue Market Share by Company (2020-2025)
Table 41. Latin America Clinical Reference Laboratory Molecular Diagnostic Services Market Size by Type (2020-2025) & (US$ Million)
Table 42. Latin America Clinical Reference Laboratory Molecular Diagnostic Services Market Size by Application (2020-2025) & (US$ Million)
Table 43. Middle East & Africa Clinical Reference Laboratory Molecular Diagnostic Services Revenue by Company (2020-2025) & (US$ Million)
Table 44. Middle East & Africa Clinical Reference Laboratory Molecular Diagnostic Services Revenue Market Share by Company (2020-2025)
Table 45. Middle East & Africa Clinical Reference Laboratory Molecular Diagnostic Services Market Size by Type (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Clinical Reference Laboratory Molecular Diagnostic Services Market Size by Application (2020-2025) & (US$ Million)
Table 47. Quest Diagnostics Company Details
Table 48. Quest Diagnostics Business Overview
Table 49. Quest Diagnostics Clinical Reference Laboratory Molecular Diagnostic Services Product
Table 50. Quest Diagnostics Revenue in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025) & (US$ Million)
Table 51. Quest Diagnostics Recent Development
Table 52. Eurofins Scientific Company Details
Table 53. Eurofins Scientific Business Overview
Table 54. Eurofins Scientific Clinical Reference Laboratory Molecular Diagnostic Services Product
Table 55. Eurofins Scientific Revenue in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025) & (US$ Million)
Table 56. Eurofins Scientific Recent Development
Table 57. Mayo Clinic Laboratories Company Details
Table 58. Mayo Clinic Laboratories Business Overview
Table 59. Mayo Clinic Laboratories Clinical Reference Laboratory Molecular Diagnostic Services Product
Table 60. Mayo Clinic Laboratories Revenue in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025) & (US$ Million)
Table 61. Mayo Clinic Laboratories Recent Development
Table 62. Genomic Health Company Details
Table 63. Genomic Health Business Overview
Table 64. Genomic Health Clinical Reference Laboratory Molecular Diagnostic Services Product
Table 65. Genomic Health Revenue in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025) & (US$ Million)
Table 66. Genomic Health Recent Development
Table 67. Clinical Reference Laboratory Company Details
Table 68. Clinical Reference Laboratory Business Overview
Table 69. Clinical Reference Laboratory Clinical Reference Laboratory Molecular Diagnostic Services Product
Table 70. Clinical Reference Laboratory Revenue in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025) & (US$ Million)
Table 71. Clinical Reference Laboratory Recent Development
Table 72. Molecular Pathology Laboratory Network Company Details
Table 73. Molecular Pathology Laboratory Network Business Overview
Table 74. Molecular Pathology Laboratory Network Clinical Reference Laboratory Molecular Diagnostic Services Product
Table 75. Molecular Pathology Laboratory Network Revenue in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025) & (US$ Million)
Table 76. Molecular Pathology Laboratory Network Recent Development
Table 77. Opko Health Company Details
Table 78. Opko Health Business Overview
Table 79. Opko Health Clinical Reference Laboratory Molecular Diagnostic Services Product
Table 80. Opko Health Revenue in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025) & (US$ Million)
Table 81. Opko Health Recent Development
Table 82. NantHealth Company Details
Table 83. NantHealth Business Overview
Table 84. NantHealth Clinical Reference Laboratory Molecular Diagnostic Services Product
Table 85. NantHealth Revenue in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025) & (US$ Million)
Table 86. NantHealth Recent Development
Table 87. ARUP Laboratories Company Details
Table 88. ARUP Laboratories Business Overview
Table 89. ARUP Laboratories Clinical Reference Laboratory Molecular Diagnostic Services Product
Table 90. ARUP Laboratories Revenue in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025) & (US$ Million)
Table 91. ARUP Laboratories Recent Development
Table 92. Viant Medical Company Details
Table 93. Viant Medical Business Overview
Table 94. Viant Medical Clinical Reference Laboratory Molecular Diagnostic Services Product
Table 95. Viant Medical Revenue in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025) & (US$ Million)
Table 96. Viant Medical Recent Development
Table 97. Sonic Healthcare Company Details
Table 98. Sonic Healthcare Business Overview
Table 99. Sonic Healthcare Clinical Reference Laboratory Molecular Diagnostic Services Product
Table 100. Sonic Healthcare Revenue in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025) & (US$ Million)
Table 101. Sonic Healthcare Recent Development
Table 102. Fulgent Genetics Company Details
Table 103. Fulgent Genetics Business Overview
Table 104. Fulgent Genetics Clinical Reference Laboratory Molecular Diagnostic Services Product
Table 105. Fulgent Genetics Revenue in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025) & (US$ Million)
Table 106. Fulgent Genetics Recent Development
Table 107. Laboratory Corporation of America Holdings Company Details
Table 108. Laboratory Corporation of America Holdings Business Overview
Table 109. Laboratory Corporation of America Holdings Clinical Reference Laboratory Molecular Diagnostic Services Product
Table 110. Laboratory Corporation of America Holdings Revenue in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025) & (US$ Million)
Table 111. Laboratory Corporation of America Holdings Recent Development
Table 112. BGI Genomics Company Details
Table 113. BGI Genomics Business Overview
Table 114. BGI Genomics Clinical Reference Laboratory Molecular Diagnostic Services Product
Table 115. BGI Genomics Revenue in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025) & (US$ Million)
Table 116. BGI Genomics Recent Development
Table 117. Daan Gene Company Details
Table 118. Daan Gene Business Overview
Table 119. Daan Gene Clinical Reference Laboratory Molecular Diagnostic Services Product
Table 120. Daan Gene Revenue in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025) & (US$ Million)
Table 121. Daan Gene Recent Development
Table 122. Guangdong Hybribio Biotech Company Details
Table 123. Guangdong Hybribio Biotech Business Overview
Table 124. Guangdong Hybribio Biotech Clinical Reference Laboratory Molecular Diagnostic Services Product
Table 125. Guangdong Hybribio Biotech Revenue in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025) & (US$ Million)
Table 126. Guangdong Hybribio Biotech Recent Development
Table 127. Jiangsu Bioperfectus Technologies Company Details
Table 128. Jiangsu Bioperfectus Technologies Business Overview
Table 129. Jiangsu Bioperfectus Technologies Clinical Reference Laboratory Molecular Diagnostic Services Product
Table 130. Jiangsu Bioperfectus Technologies Revenue in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025) & (US$ Million)
Table 131. Jiangsu Bioperfectus Technologies Recent Development
Table 132. Maccura Biotechnology Company Details
Table 133. Maccura Biotechnology Business Overview
Table 134. Maccura Biotechnology Clinical Reference Laboratory Molecular Diagnostic Services Product
Table 135. Maccura Biotechnology Revenue in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025) & (US$ Million)
Table 136. Maccura Biotechnology Recent Development
Table 137. Guangzhou Wondfo Biotech Company Details
Table 138. Guangzhou Wondfo Biotech Business Overview
Table 139. Guangzhou Wondfo Biotech Clinical Reference Laboratory Molecular Diagnostic Services Product
Table 140. Guangzhou Wondfo Biotech Revenue in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025) & (US$ Million)
Table 141. Guangzhou Wondfo Biotech Recent Development
Table 142. GoBroad Healthcare Company Details
Table 143. GoBroad Healthcare Business Overview
Table 144. GoBroad Healthcare Clinical Reference Laboratory Molecular Diagnostic Services Product
Table 145. GoBroad Healthcare Revenue in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025) & (US$ Million)
Table 146. GoBroad Healthcare Recent Development
Table 147. Clinical Reference Laboratory Molecular Diagnostic Services Market Trends
Table 148. Clinical Reference Laboratory Molecular Diagnostic Services Market Drivers
Table 149. Clinical Reference Laboratory Molecular Diagnostic Services Market Challenges
Table 150. Clinical Reference Laboratory Molecular Diagnostic Services Market Restraints
Table 151. Research Programs/Design for This Report
Table 152. Key Data Information from Secondary Sources
Table 153. Key Data Information from Primary Sources
List of Figures
Figure 1. Clinical Reference Laboratory Molecular Diagnostic Services Product Picture
Figure 2. Global Clinical Reference Laboratory Molecular Diagnostic Services Market Share by Type: 2024 VS 2031
Figure 3. Nucleic Acid Amplification Testing Features
Figure 4. Nucleic Acid Hybridization Testing Features
Figure 5. Gene Sequencing Features
Figure 6. Gene Chip Technology Features
Figure 7. Others Features
Figure 8. Global Clinical Reference Laboratory Molecular Diagnostic Services Market Share by Application: 2024 VS 2031
Figure 9. Disease Diagnosis
Figure 10. Drug Development
Figure 11. Personalized Healthcare
Figure 12. Medicolegal Expertise
Figure 13. Others
Figure 14. Clinical Reference Laboratory Molecular Diagnostic Services Report Years Considered
Figure 15. Global Clinical Reference Laboratory Molecular Diagnostic Services Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Clinical Reference Laboratory Molecular Diagnostic Services Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Clinical Reference Laboratory Molecular Diagnostic Services Revenue Market Share by Region: 2020 VS 2024
Figure 18. North America Clinical Reference Laboratory Molecular Diagnostic Services Revenue (US$ Million) Growth Rate (2020-2031)
Figure 19. Europe Clinical Reference Laboratory Molecular Diagnostic Services Revenue (US$ Million) Growth Rate (2020-2031)
Figure 20. Asia-Pacific Clinical Reference Laboratory Molecular Diagnostic Services Revenue (US$ Million) Growth Rate (2020-2031)
Figure 21. Latin America Clinical Reference Laboratory Molecular Diagnostic Services Revenue (US$ Million) Growth Rate (2020-2031)
Figure 22. Middle East & Africa Clinical Reference Laboratory Molecular Diagnostic Services Revenue (US$ Million) Growth Rate (2020-2031)
Figure 23. Global Clinical Reference Laboratory Molecular Diagnostic Services Market Share by Players in 2024
Figure 24. Global Top Clinical Reference Laboratory Molecular Diagnostic Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Clinical Reference Laboratory Molecular Diagnostic Services as of 2024)
Figure 25. The Top 10 and 5 Players Market Share by Clinical Reference Laboratory Molecular Diagnostic Services Revenue in 2024
Figure 26. North America Clinical Reference Laboratory Molecular Diagnostic Services Market Share by Type (2020-2025)
Figure 27. North America Clinical Reference Laboratory Molecular Diagnostic Services Market Share by Application (2020-2025)
Figure 28. Europe Clinical Reference Laboratory Molecular Diagnostic Services Market Share by Type (2020-2025)
Figure 29. Europe Clinical Reference Laboratory Molecular Diagnostic Services Market Share by Application (2020-2025)
Figure 30. Asia-Pacific Clinical Reference Laboratory Molecular Diagnostic Services Market Share by Type (2020-2025)
Figure 31. Asia-Pacific Clinical Reference Laboratory Molecular Diagnostic Services Market Share by Application (2020-2025)
Figure 32. Latin America Clinical Reference Laboratory Molecular Diagnostic Services Market Share by Type (2020-2025)
Figure 33. Latin America Clinical Reference Laboratory Molecular Diagnostic Services Market Share by Application (2020-2025)
Figure 34. Middle East & Africa Clinical Reference Laboratory Molecular Diagnostic Services Market Share by Type (2020-2025)
Figure 35. Middle East & Africa Clinical Reference Laboratory Molecular Diagnostic Services Market Share by Application (2020-2025)
Figure 36. Quest Diagnostics Revenue Growth Rate in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025)
Figure 37. Eurofins Scientific Revenue Growth Rate in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025)
Figure 38. Mayo Clinic Laboratories Revenue Growth Rate in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025)
Figure 39. Genomic Health Revenue Growth Rate in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025)
Figure 40. Clinical Reference Laboratory Revenue Growth Rate in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025)
Figure 41. Molecular Pathology Laboratory Network Revenue Growth Rate in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025)
Figure 42. Opko Health Revenue Growth Rate in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025)
Figure 43. NantHealth Revenue Growth Rate in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025)
Figure 44. ARUP Laboratories Revenue Growth Rate in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025)
Figure 45. Viant Medical Revenue Growth Rate in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025)
Figure 46. Sonic Healthcare Revenue Growth Rate in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025)
Figure 47. Fulgent Genetics Revenue Growth Rate in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025)
Figure 48. Laboratory Corporation of America Holdings Revenue Growth Rate in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025)
Figure 49. BGI Genomics Revenue Growth Rate in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025)
Figure 50. Daan Gene Revenue Growth Rate in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025)
Figure 51. Guangdong Hybribio Biotech Revenue Growth Rate in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025)
Figure 52. Jiangsu Bioperfectus Technologies Revenue Growth Rate in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025)
Figure 53. Maccura Biotechnology Revenue Growth Rate in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025)
Figure 54. Guangzhou Wondfo Biotech Revenue Growth Rate in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025)
Figure 55. GoBroad Healthcare Revenue Growth Rate in Clinical Reference Laboratory Molecular Diagnostic Services Business (2020-2025)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What is the annual compound growth rate of the global Clinical Reference Laboratory Molecular Diagnostic Services market size from 2025 to 2031?
The annual compound growth rate of the global Clinical Reference Laboratory Molecular Diagnostic Services market is 5.8% 2025 to 2031.
Which region is expected to have the highest market share?
What was the global market size of Clinical Reference Laboratory Molecular Diagnostic Services in 2025?
What was the global market size of Clinical Reference Laboratory Molecular Diagnostic Services in 2031?
Which companies rank high in the global Clinical Reference Laboratory Molecular Diagnostic Services market?
Related Reports
Global Clinical Reference Laboratory Molecular Diagnostic Services Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Clinical Reference Laboratory Molecular Diagnostic Services market is projected to grow from US$ 6876 million in 2025 to US$ 10140 million by 2032, at a CAGR of 5.8% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-03-11
Pages: 150
USD 4900.00
(Single User License)
Global Clinical Reference Laboratory Molecular Diagnostic Services Market Research Report 2026
The global Clinical Reference Laboratory Molecular Diagnostic Services market was valued at US$ 6876 million in 2025 and is anticipated to reach US$ 10140 million by 2032, at a CAGR of 5.8% from 2026 to 2032.
Published Date: 2026-03-11
Pages: 131
USD 2900.00
(Single User License)
Global Clinical Reference Laboratory Molecular Diagnostic Services Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Clinical Reference Laboratory Molecular Diagnostic Services market size was US$ 6876 million in 2025 and is forecast to reach a readjusted size of US$ 10140 million by 2032 with a CAGR of 5.8% during the forecast period 2026-2032.
Published Date: 2026-03-11
Pages: 104
USD 4250.00
(Single User License)
Clinical Reference Laboratory Molecular Diagnostic Services - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Clinical Reference Laboratory Molecular Diagnostic Services was estimated to be worth US$ 6876 million in 2025 and is projected to reach US$ 10140 million, growing at a CAGR of 5.8% from 2026 to 2032.
Published Date: 2026-03-09
Pages: 140
USD 3950.00
(Single User License)
Clinical Reference Laboratory Molecular Diagnostic Services - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Clinical Reference Laboratory Molecular Diagnostic Services was estimated to be worth US$ 6500 million in 2024 and is forecast to a readjusted size of US$ 9639 million by 2031 with a CAGR of 5.8% during the forecast period 2025-2031.
Published Date: 2025-04-13
Pages: 128
USD 3950.00
(Single User License)
Global Clinical Reference Laboratory Molecular Diagnostic Services Market Insights, Forecast to 2031
The global Clinical Reference Laboratory Molecular Diagnostic Services market is projected to grow from US$ 6876 million in 2025 to US$ 9639 million by 2031, at a Compound Annual Growth Rate (CAGR) of 5.8% during the forecast period.
Published Date: 2025-04-13
Pages: 150
USD 4900.00
(Single User License)
Global Clinical Reference Laboratory Molecular Diagnostic Services Market Research Report 2025
The global market for Clinical Reference Laboratory Molecular Diagnostic Services was valued at US$ 6500 million in the year 2024 and is projected to reach a revised size of US$ 9639 million by 2031, growing at a CAGR of 5.8% during the forecast period.
Published Date: 2025-04-13
Pages: 92
USD 2900.00
(Single User License)
Global Clinical Reference Laboratory Molecular Diagnostic Services Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Clinical Reference Laboratory Molecular Diagnostic Services market is projected to grow from US$ 6876 million in 2025 to US$ 10140 million by 2032, at a CAGR of 5.8% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-11
Pages: 150
USD 4900.00 (Single User License)Global Clinical Reference Laboratory Molecular Diagnostic Services Market Research Report 2026
The global Clinical Reference Laboratory Molecular Diagnostic Services market was valued at US$ 6876 million in 2025 and is anticipated to reach US$ 10140 million by 2032, at a CAGR of 5.8% from 2026 to 2032.
Published: 2026-03-11
Pages: 131
USD 2900.00 (Single User License)Global Clinical Reference Laboratory Molecular Diagnostic Services Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Clinical Reference Laboratory Molecular Diagnostic Services market size was US$ 6876 million in 2025 and is forecast to reach a readjusted size of US$ 10140 million by 2032 with a CAGR of 5.8% during the forecast period 2026-2032.
Published: 2026-03-11
Pages: 104
USD 4250.00 (Single User License)Clinical Reference Laboratory Molecular Diagnostic Services - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Clinical Reference Laboratory Molecular Diagnostic Services was estimated to be worth US$ 6876 million in 2025 and is projected to reach US$ 10140 million, growing at a CAGR of 5.8% from 2026 to 2032.
Published: 2026-03-09
Pages: 140
USD 3950.00 (Single User License)Clinical Reference Laboratory Molecular Diagnostic Services - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Clinical Reference Laboratory Molecular Diagnostic Services was estimated to be worth US$ 6500 million in 2024 and is forecast to a readjusted size of US$ 9639 million by 2031 with a CAGR of 5.8% during the forecast period 2025-2031.
Published: 2025-04-13
Pages: 128
USD 3950.00 (Single User License)Global Clinical Reference Laboratory Molecular Diagnostic Services Market Insights, Forecast to 2031
The global Clinical Reference Laboratory Molecular Diagnostic Services market is projected to grow from US$ 6876 million in 2025 to US$ 9639 million by 2031, at a Compound Annual Growth Rate (CAGR) of 5.8% during the forecast period.
Published: 2025-04-13
Pages: 150
USD 4900.00 (Single User License)Global Clinical Reference Laboratory Molecular Diagnostic Services Market Research Report 2025
The global market for Clinical Reference Laboratory Molecular Diagnostic Services was valued at US$ 6500 million in the year 2024 and is projected to reach a revised size of US$ 9639 million by 2031, growing at a CAGR of 5.8% during the forecast period.
Published: 2025-04-13
Pages: 92
USD 2900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4250.00
USD 6375.00
USD 8500.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now